Fig. 1From: Cost-effectiveness analysis of the prevention of mother-to-child transmission of HIVMarkov model of HIV/AIDS for ART. AIDS acquired immunodeficiency syndrome, ART antiretroviral therapy, HIV human immunodeficiency virusBack to article page